The more I learn and experience about investing, the more convinced I become that doing nothing is the best strategy for long-term success in a portfolio. I believe that time in the market is more important than timing the market. This is the conclusion I reach in an earlier article on the topic:
"The lesson to long-term investors is clear; it doesn't matter whether we are in a bull market or bear market. The goal is to dollar cost average each month in quality dividend growth stocks selling at attractive valuations, reinvest dividends, and hold patiently for the next 20 – 30 years. I cannot emphasize quality factor, since the quality companies are more likely to survive a deep recession unscathed, and continue paying and growing dividends, even during the hardest of times. "
When I was much less knowledgeable and experienced, I operated under the assumption that it is easy to just switch in and out of stocks, and thus outguess the markets. In reality, this was a foolish approach, since nobody can consistently go in and out of stocks. This is because it costs a lot in terms of taxes, commissions and time to sell a company and buy another one. The biggest cost of course is opportunity cost, since in the majority of scenarios I would have been better off, had I simply stayed put, and allocated my dividends in the best ideas at the time. Hence, the only time I have considered selling is if a dividend is cut, or a position becomes so overpriced or take such a weight in my portfolio, that it would be prudent to trim or eliminate it.
This belief has been further reinforced by a few examples that I have come across. I covered the first example a few months ago, when I discussed the performance of the original members of the S&P 500 from 1957. The second example is from a completely passive fund that was set up 78 years ago.
The Corporate Leaders Trust was created in 1935 with an equal number of common stock shares of the 30 leading U.S. companies at the time. The goal was to seek long term capital growth and income through investment generally in an equal number of shares of common stock of a fixed list of American blue chip corporations. After 78 years, it is currently invested in a total of 23 leading U.S. corporations. The trust cannot purchase new companies, so holdings have changed only due to spin-offs, dividend eliminations, or mergers since fund inception. The Fund is a passively managed grantor trust registered with the SEC as a unit investment trust. The fund was expected to be liquidated by 2015, but its life has since been extended through 2100.
The original 30 securities were:
The current 23 holdings are:
Source: Fund Website
There were only a few outright failures in the portfolio of the fund. However, what really helped results was the fact that the trust let winners run for as long as possible. As a dividend investor, I have learned that I should not sell, even if the stock I own is up over 1,000%. This is because it does not make sense to get rid of your winners, that will propel your portfolio forward, both in terms of capital appreciation and dividend growth. In a long-term portfolio that is held for generations, one could reasonably expect to have positions that result in mind-boggling returns over those decades.
The changes are as a result of acquisitions, spin-offs, and dividend eliminations. When a company eliminates dividends or goes bankrupt, it is sold out.
A $10,000 investment in 1941 would be worth $18.40 million by the end of 2014, and generating annual dividend income of almost $400,000/year at a current yield of 2.23%. Source: Prospectus
The interesting fact is that since 1970, it has managed to outperform the S&P 500, while being completely passively managed. Source: Fund Website
This is a testament of the power of selecting the leading dividend paying blue chips of the time, and then patiently holding for generations. Investors in the trust ignored all the fads of the next 78 years, and did really well by investing in businesses that stood the test of time. A diverse portfolio of mature blue chip companies with enduring business models will generate loads of excess cash for their shareholders, which could then be reinvested into more shares at depressed values.
This is also a testament to the fact that the blue chip holdings are not expected to grow as rapidly as companies in hot new sectors, which is why those blue chips are perennially undervalued. As a result, dividends are reinvested into undervalued shares, which further turbocharges returns. When you have low expectations, valuations are low. However, if you manage to generate consistent earnings growth, this can result in very good investor returns. This is a superior strategy to the one where hot growth stocks are chased by unsuspecting investors who pay dearly for the chance to buy future growth, which rarely materialized to the extend expected. When you invest in a stock or a sector with inflated expectations, you pay a premium for it. If things do not go as expected, the valuation compression and the low increase in earnings serve as a double-whammy that prevents investors from realizing a gain.
If you really sit and think about it, long-term investing is the best ally of the individual dividend investor. It allows you to quietly compound your capital by focusing only on quality blue chip dividend paying companies that have enduring business models, while ignoring the everyday noise that tries to make you to do something, when in reality there is no need for you to act.
A 3% yield today might not sound like a lot today, but if you reinvest those dividends that grow at 6% – 7% annually for the next 30 – 40 – 50 years, the level of dividend income would be mind boggling. If you also look at that from the perspective of a company that grows earnings by 6% – 7%/year for that period of time, your wealth would be increasing a lot as well. The small yield today is the seed that will bring fruit to you and your family or charitable cause for decades to come. Do not waste it, but do the smart thing by investing it and watching it turn into a beautiful tree.
So to summarize, this fund proves that a diversified portfolio of blue chip companies that regularly pay dividends, and adapt to the ever changing economy is a great way to build and maintain wealth and income. It is a living proof that passive buy and hold dividend investing works for those who are patient and have a long-term mindset.
Full Disclosure:I have a position in T, BRK/B, CVX, XOM, GE, PG, UNP
- Time in the market is more important than timing the market
- The Perfect Dividend Portfolio
- Where are the original Dividend Aristocrats now?
- Quality Dividend Stocks versus Growth Stocks
- What drives future investment returns?
I have built my portfolio of dividend growth stocks over the past 8 – 9 years, by following a disciplined approach to investing . Having an...
Each week, I go through the list of dividend increases in order to monitor performance of existing holdings, and uncover hidden dividend ge...
This is a guest post written by Ben Reynolds at Sure Dividend . Sure Dividend helps individual investors build high quality dividend gro...
This is a guest post by Mike, aka The Dividend Guy. He authors The Dividend Guy Blog since 2010 and manages portfolios at Dividend Stocks ...
Each week I review the list of dividend increases . This is helpful in monitoring existing dividend holdings, and monitoring the breadth of ...
Over the past week, we have seen some crazy turbulence in stock prices. When I saw S&P 500 futures down by 5% on Election Day, I was n...
HCP, Inc. (HCP) is a real estate investment trust that invests in properties serving the healthcare industry including sectors of healthcare...
A dividend king , is a company that has managed to boost dividends to shareholders every single year for at least 50 years in a row. There a...
Regular readers know that I have assets held in taxable and non-taxable accounts . Taxable account provide me with more flexibility in th...
CVS Health Corporation (CVS), together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmac...